Mass spectrometry approaches to glycomic and glycoproteomic analyses
Glycomic and glycoproteomic analyses involve the characterization of oligosaccharides
(glycans) conjugated to proteins. Glycans are produced through a complicated nontemplate …
(glycans) conjugated to proteins. Glycans are produced through a complicated nontemplate …
Recent advances in the analysis of complex glycoproteins
Notes 408 Biographies 408 Acknowledgments 409 References 409 The enormous
structural diversity of glycoconjugates mirrors their myriad biological functions in prokaryotic …
structural diversity of glycoconjugates mirrors their myriad biological functions in prokaryotic …
Options of the main derivatization approaches for analytical ESI and MALDI mass spectrometry
VG Zaikin, RS Borisov - Critical Reviews in Analytical Chemistry, 2022 - Taylor & Francis
The inclusion of preliminary chemical labeling (derivatization) in the analysis process by
such powerful and widespread methods as electrospray ionization (ESI) and matrix-assisted …
such powerful and widespread methods as electrospray ionization (ESI) and matrix-assisted …
Organic matrices, ionic liquids, and organic matrices@ nanoparticles assisted laser desorption/ionization mass spectrometry
HN Abdelhamid - TrAC Trends in Analytical Chemistry, 2017 - Elsevier
The applications of organic matrices for matrix assisted laser desorption/ionization mass
spectrometry (MALDI-MS) are reviewed. Recent advances of MALDI-MS using organic …
spectrometry (MALDI-MS) are reviewed. Recent advances of MALDI-MS using organic …
Analysis of carbohydrates and glycoconjugates by matrix‐assisted laser desorption/ionization mass spectrometry: An update for 2013–2014
DJ Harvey - Mass Spectrometry Reviews, 2018 - Wiley Online Library
This review is the eighth update of the original article published in 1999 on the application of
Matrix‐assisted laser desorption/ionization mass spectrometry (MALDI) mass spectrometry …
Matrix‐assisted laser desorption/ionization mass spectrometry (MALDI) mass spectrometry …
MALDI-MS analysis of sialylated N-glycan linkage isomers using solid-phase two step derivatization method
H Li, W Gao, X Feng, BF Liu, X Liu - Analytica chimica acta, 2016 - Elsevier
Sialic acids usually locate at the terminal of many glycan structures in either α (2, 3) or α (2,
6) linkage, playing different roles in various biological and pathological processes. Several …
6) linkage, playing different roles in various biological and pathological processes. Several …
Glycan analysis for protein therapeutics
X Yang, MG Bartlett - Journal of Chromatography B, 2019 - Elsevier
Glycosylation can be a critical quality attribute for protein therapeutics due to its extensive
impact on product safety and efficacy. Glycan characterization is important in the process of …
impact on product safety and efficacy. Glycan characterization is important in the process of …
Duplex stable isotope labeling (DuSIL) for simultaneous quantitation and distinction of sialylated and neutral N-glycans by MALDI-MS
L Wei, Y Cai, L Yang, Y Zhang, H Lu - Analytical chemistry, 2018 - ACS Publications
Quantitative N-glycomics provides an effective tool for detecting glycosylation changes in
cancer and other diseases. However, the lability of sialic acid and its lower ionization …
cancer and other diseases. However, the lability of sialic acid and its lower ionization …
Structural characterization of serum N-glycans by methylamidation, fluorescent labeling, and analysis by microchip electrophoresis
I Mitra, CM Snyder, X Zhou, MI Campos… - Analytical …, 2016 - ACS Publications
To characterize the structures of N-glycans derived from human serum, we report a strategy
that combines microchip electrophoresis, standard addition, enzymatic digestion, and matrix …
that combines microchip electrophoresis, standard addition, enzymatic digestion, and matrix …
Methods for the absolute quantification of N-glycan biomarkers
J Etxebarria, NC Reichardt - Biochimica et Biophysica Acta (BBA)-General …, 2016 - Elsevier
Background Many treatment options especially for cancer show a low efficacy for the
majority of patients demanding improved biomarker panels for patient stratification. Changes …
majority of patients demanding improved biomarker panels for patient stratification. Changes …